The Effect of Chinese Herbal Formula (KSY) on HCV Carrier With Abnormal Liver Function
NCT ID: NCT01708733
Last Updated: 2014-05-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE2/PHASE3
57 participants
INTERVENTIONAL
2012-08-31
2014-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Nation-wide Hepatitis C Virus (HCV) Registry in Taiwan
NCT03200379
Study on the Optimal Strategy for Acute-on-chronic Liver Failure With Integrative Treatment
NCT03577938
Effect of Cyanobacteria Patients With Chronic Hepatitis B Surface Antigen Quantitative Concentration
NCT02953600
The Follow-up Study of Chronic Hepatitis B Patients With Liver Cirrhosis Receiving Anti-HBV Therapy
NCT01957618
Prospective Observational Study of Disease Progression in Chronic Hepatitis C
NCT02011932
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
KSY diluted
KSY diluted, 100mg decoction by mouth per day for 6 weeks
No interventions assigned to this group
KSY
KSY, 100mg decoction by mouth per day for 6 weeks
KSY
Chinese herbal formula
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
KSY
Chinese herbal formula
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Taipei City Hospital
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Chung-Hua Hsu
chief medical officer
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Taipei City Hospital
Taipei, Taiwan, Taiwan
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
101001-62-010
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.